Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 2,935,903 |
|
|||||
| News | - | ||||||
| Day High | 0.0001 | Low High |
|||||
| Day Low | 0.0001 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Item 9 Labs Corporation (CE) | INLB | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.0001 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.0001 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 65 | 2,935,903 | US$ 0.0001 | US$ 294 | - | 0.0001 - 0.10 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 12:43:11 | 1,343,282 | US$ 0.0001 | USD |
Item 9 Labs Corporation (CE) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 10.43k | 104.34M | 20.86M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Item 9 Labs (CE) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 2/21/2024 | 10:12 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 8/21/2023 | 16:11 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 8/14/2023 | 16:18 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
| 7/20/2023 | 16:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 7/07/2023 | 16:16 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INLB Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 219,879 | 0.00 | 0.00% |
| 1 Month | 0.0001 | 0.0002 | 0.0001 | 0.0001769 | 557,172 | 0.00 | 0.00% |
| 3 Months | 0.0004 | 0.0005 | 0.0001 | 0.0002711 | 11,519,049 | -0.0003 | -75.00% |
| 6 Months | 0.0017 | 0.004 | 0.0001 | 0.0006437 | 12,429,378 | -0.0016 | -94.12% |
| 1 Year | 0.0355 | 0.10 | 0.0001 | 0.0010035 | 6,489,940 | -0.0354 | -99.72% |
| 3 Years | 3.12 | 3.7385 | 0.0001 | 0.0061562 | 2,118,809 | -3.12 | -100.00% |
| 5 Years | 5.14 | 5.50 | 0.0001 | 0.0123805 | 1,294,599 | -5.14 | -100.00% |
Item 9 Labs (CE) Description
| Item 9 Labs Corp. (OTCQX: INLB) is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The award-winning Item 9 Labs brand specializes in best-in-class products and user experience across several cannabis categories. The company also offers a unique dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. Item 9 Labs brings the best industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation. The veteran management team combines a diverse skill set with deep experience in the cannabis sector, franchising, and the capital markets to lead a new generation of public cannabis companies that provide transparency, consistency, and well-being. Headquartered in Arizona, the company is currently expanding its operations space by 640,000+ square feet on its 50-acre site, one of the largest properties in Arizona zoned to grow and cultivate flower. For additional information, visit item9labscorp.com. |
